Literature DB >> 25253977

A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation.

Ji Eun Kim1, Tae-Geun Gweon1, Chang Dong Yeo1, Young-Seok Cho1, Gi Jun Kim1, Jae Young Kim1, Jong Wook Kim1, Hyunho Kim1, Hye Won Lee1, Taeseok Lim1, Hyoju Ham1, Hyun Jin Oh1, Yeongbok Lee1, Jaeho Byeon1, Sung Soo Park1.   

Abstract

Acute respiratory distress syndrome is a life-threatening disorder caused mainly by pneumonia. Clostridium difficile infection (CDI) is a common nosocomial diarrheal disease. Disruption of normal intestinal flora by antibiotics is the main risk factor for CDI. The use of broad-spectrum antibiotics for serious medical conditions can make it difficult to treat CDI complicated by acute respiratory distress syndrome. Fecal microbiota transplantation is a highly effective treatment in patients with refractory CDI. Here we report on a patient with refractory CDI and acute respiratory distress syndrome caused by pneumonia who was treated with fecal microbiota transplantation.

Entities:  

Keywords:  Acute respiratory distress syndrome; Clostridium difficile infection; Fecal microbiota transplantation

Mesh：

Substances：

Year:  2014        PMID： 25253977      PMCID： PMC4168110          DOI： 10.3748/wjg.v20.i35.12687

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  9 in total

1.  Clostridium difficile and acute respiratory distress syndrome.

Authors:  Sindhu S Jacob; Justin C Sebastian; Debra Hiorns; Sony Jacob; Prashant K Mukerjee
Journal:  Heart Lung       Date:  2004 Jul-Aug       Impact factor: 2.210

Review 2.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

3.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

Review 4.  Acute respiratory distress syndrome and acute lung injury.

Authors:  A Dushianthan; M P W Grocott; A D Postle; R Cusack
Journal:  Postgrad Med J       Date:  2011-06-04       Impact factor: 2.401

5.  Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

Authors:  Lawrence J Brandt; Olga C Aroniadis; Mark Mellow; Amy Kanatzar; Colleen Kelly; Tina Park; Neil Stollman; Faith Rohlke; Christina Surawicz
Journal:  Am J Gastroenterol       Date:  2012-03-27       Impact factor: 10.864

6.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

7.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

Review 8.  Clinical recognition and diagnosis of Clostridium difficile infection.

Authors:  John G Bartlett; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

Review 9.  Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review.

Authors:  Jason Phua; Joan R Badia; Neill K J Adhikari; Jan O Friedrich; Robert A Fowler; Jeff M Singh; Damon C Scales; David R Stather; Amanda Li; Andrew Jones; David J Gattas; David Hallett; George Tomlinson; Thomas E Stewart; Niall D Ferguson
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405
  9 in total
  3 in total

1.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

Review 2.  Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives.

Authors:  Hyun Ho Choi; Young-Seok Cho
Journal:  Clin Endosc       Date:  2016-03-09

3.  Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country.

Authors:  Tae-Geun Gweon; Jinsu Kim; Chul-Hyun Lim; Jae Myung Park; Dong-Gun Lee; In Seok Lee; Young-Seok Cho; Sang Woo Kim; Myung-Gyu Choi
Journal:  Gastroenterol Res Pract       Date:  2016-04-05       Impact factor: 2.260
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.